Rigel bags first FDA approval
admin 18th April 2018 Uncategorised 0Rigel Pharmaceuticals has bagged its first FDA approval, with a green light to market Tavalisse for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have failed to respond to previous treatment.
More: Rigel bags first FDA approval
Source: News